Fritsche A - Search Results

1

Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial.

Kullmann S, Hummel J, Wagner R, Dannecker C, Vosseler A, Fritsche L, Veit R, Kantartzis K, Machann J, Birkenfeld AL, Stefan N, Häring HU, Peter A, Preissl H, Fritsche A, Heni M. Kullmann S, et al. Among authors: fritsche l, fritsche a. Diabetes Care. 2022 Feb 1;45(2):398-406. doi: 10.2337/dc21-1136. Diabetes Care. 2022. PMID: 34716213 Free PMC article. Clinical Trial.

2

Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects.

Fritsche A, Stumvoll M, Grüb M, Sieslack S, Renn W, Schmülling RM, Häring HU, Gerich JE. Fritsche A, et al. Diabetes Care. 1998 Sep;21(9):1505-10. doi: 10.2337/diacare.21.9.1505. Diabetes Care. 1998. PMID: 9727899

3

Evidence for inhibition of leptin secretion by catecholamines in man.

Fritsche A, Wahl HG, Metzinger E, Renn W, Kellerer M, Häring H, Stumvoll M. Fritsche A, et al. Exp Clin Endocrinol Diabetes. 1998;106(5):415-8. doi: 10.1055/s-0029-1212008. Exp Clin Endocrinol Diabetes. 1998. PMID: 9831308

4

Reversal of hypoglycemia unawareness in a long-term type 1 diabetic patient by improvement of beta-adrenergic sensitivity after prevention of hypoglycemia.

Fritsche A, Stumvoll M, Häring HU, Gerich JE. Fritsche A, et al. J Clin Endocrinol Metab. 2000 Feb;85(2):523-5. doi: 10.1210/jcem.85.2.6353. J Clin Endocrinol Metab. 2000. PMID: 10690848

5

Long term effect of a structured inpatient diabetes teaching and treatment programme in type 2 diabetic patients: influence of mode of follow-up.

Fritsche A, Stumvoll M, Goebbel S, Reinauer KM, Schmülling RM, Häring HU. Fritsche A, et al. Diabetes Res Clin Pract. 1999 Nov;46(2):135-41. doi: 10.1016/s0168-8227(99)00081-9. Diabetes Res Clin Pract. 1999. PMID: 10724092

6

A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.

Fritsche A, Stefan N, Hardt E, Schützenauer S, Häring H, Stumvoll M. Fritsche A, et al. Eur J Clin Invest. 2000 May;30(5):411-8. doi: 10.1046/j.1365-2362.2000.00649.x. Eur J Clin Invest. 2000. PMID: 10809901 Clinical Trial.

7

A 60 minute hyperglycemic clamp is sufficient to assess both phases of insulin secretion.

Stumvoll M, Fritsche A, Stefan N, Häring H. Stumvoll M, et al. Among authors: fritsche a. Horm Metab Res. 2000 Jun;32(6):230-2. doi: 10.1055/s-2007-978626. Horm Metab Res. 2000. PMID: 10898552

8

Intensive insulin therapy combined with metformin in obese type 2 diabetic patients.

Fritsche A, Schmülling RM, Häring HU, Stumvoll M. Fritsche A, et al. Acta Diabetol. 2000 Mar;37(1):13-8. doi: 10.1007/s005920070030. Acta Diabetol. 2000. PMID: 10928231 Clinical Trial.

9

Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.

Fritsche A, Stefan N, Hardt E, Häring H, Stumvoll M. Fritsche A, et al. Diabetologia. 2000 Jul;43(7):852-8. doi: 10.1007/s001250051461. Diabetologia. 2000. PMID: 10952457

10

Assessment of insulin secretion from the oral glucose tolerance test in white patients with type 2 diabetes.

Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Häring H, Fritsche A, Gerich J. Stumvoll M, et al. Among authors: fritsche a. Diabetes Care. 2000 Sep;23(9):1440-1. doi: 10.2337/diacare.23.9.1440. Diabetes Care. 2000. PMID: 10977054 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters